chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Chest pain; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ept533) via an unspecified route of administration on 05Apr2021 at 06:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The relevant medical history was not reported. The patient had no known allergies to medications, food or other products. Concomitant medications included levocetirizine dihydrochloride (XYZAL) from an unknown date, for unknow indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08Apr2021 the patient experienced chest pain. No therapeutic measures were taken as a result of the reported event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event chest pain was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Akathisia, Body temperature, Dizziness, Eye pain
Clinical narrative: Arm pain; Dizziness; Difficulty walking; Severe pressure in head; Akathesia; Agitation; Eye pain; Sensitivity to light; Tinnitus; Sore throat; Vomiting; Nausea; Severe headache; 101.8 far fever; Myalgia; This is a spontaneous report from a contactable healthcare professional, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6206) via an unspecified route of administration in the left arm on 07Mar2021 at 13:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included COVID-19 infection, asthma since an unknown dates. The concomitant medications included duloxetine hydrochloride (CYMBALTA), allopurinol (ELAVIL), lurasidone hydrochloride (LATUDA), alprazolam (XANAX) and omeprazole (OMEPRAZOL) for an unknown indications, from an unknown dates and unknown if ongoing. The patient previously received levofloxacin (LEVAQUIN) and ciprofloxacin (CIPRO) and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021, at 13:30, the patient experienced severe headache, 101.8 far(Fahrenheit) fever, arm pain, myalgia, dizziness, difficulty walking, severe pressure in head, akathesia, agitation, eye pain, sensitivity to light, tinnitus, nausea, vomiting and sore throat. Therapeutic measure were taken as a result of adverse event which included treatment with non-steroidal anti-inflammatory drugs (NSAIDs). The clinical outcome of the events severe headache, 101.8 101.8 far(Fahrenheit) fever, arm pain, myalgia, dizziness, difficulty walking, severe pressure in head, akathesia, agitation, eye pain, sensitivity to light, tinnitus, nausea, vomiting and sore throat was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Head discomfort, Headache, Myalgia, Nausea
Clinical narrative: Arm pain; Dizziness; Difficulty walking; Severe pressure in head; Akathesia; Agitation; Eye pain; Sensitivity to light; Tinnitus; Sore throat; Vomiting; Nausea; Severe headache; 101.8 far fever; Myalgia; This is a spontaneous report from a contactable healthcare professional, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6206) via an unspecified route of administration in the left arm on 07Mar2021 at 13:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included COVID-19 infection, asthma since an unknown dates. The concomitant medications included duloxetine hydrochloride (CYMBALTA), allopurinol (ELAVIL), lurasidone hydrochloride (LATUDA), alprazolam (XANAX) and omeprazole (OMEPRAZOL) for an unknown indications, from an unknown dates and unknown if ongoing. The patient previously received levofloxacin (LEVAQUIN) and ciprofloxacin (CIPRO) and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021, at 13:30, the patient experienced severe headache, 101.8 far(Fahrenheit) fever, arm pain, myalgia, dizziness, difficulty walking, severe pressure in head, akathesia, agitation, eye pain, sensitivity to light, tinnitus, nausea, vomiting and sore throat. Therapeutic measure were taken as a result of adverse event which included treatment with non-steroidal anti-inflammatory drugs (NSAIDs). The clinical outcome of the events severe headache, 101.8 101.8 far(Fahrenheit) fever, arm pain, myalgia, dizziness, difficulty walking, severe pressure in head, akathesia, agitation, eye pain, sensitivity to light, tinnitus, nausea, vomiting and sore throat was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain in extremity, Photophobia, Pyrexia, Tinnitus
Clinical narrative: Arm pain; Dizziness; Difficulty walking; Severe pressure in head; Akathesia; Agitation; Eye pain; Sensitivity to light; Tinnitus; Sore throat; Vomiting; Nausea; Severe headache; 101.8 far fever; Myalgia; This is a spontaneous report from a contactable healthcare professional, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6206) via an unspecified route of administration in the left arm on 07Mar2021 at 13:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included COVID-19 infection, asthma since an unknown dates. The concomitant medications included duloxetine hydrochloride (CYMBALTA), allopurinol (ELAVIL), lurasidone hydrochloride (LATUDA), alprazolam (XANAX) and omeprazole (OMEPRAZOL) for an unknown indications, from an unknown dates and unknown if ongoing. The patient previously received levofloxacin (LEVAQUIN) and ciprofloxacin (CIPRO) and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021, at 13:30, the patient experienced severe headache, 101.8 far(Fahrenheit) fever, arm pain, myalgia, dizziness, difficulty walking, severe pressure in head, akathesia, agitation, eye pain, sensitivity to light, tinnitus, nausea, vomiting and sore throat. Therapeutic measure were taken as a result of adverse event which included treatment with non-steroidal anti-inflammatory drugs (NSAIDs). The clinical outcome of the events severe headache, 101.8 101.8 far(Fahrenheit) fever, arm pain, myalgia, dizziness, difficulty walking, severe pressure in head, akathesia, agitation, eye pain, sensitivity to light, tinnitus, nausea, vomiting and sore throat was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Arm pain; Dizziness; Difficulty walking; Severe pressure in head; Akathesia; Agitation; Eye pain; Sensitivity to light; Tinnitus; Sore throat; Vomiting; Nausea; Severe headache; 101.8 far fever; Myalgia; This is a spontaneous report from a contactable healthcare professional, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6206) via an unspecified route of administration in the left arm on 07Mar2021 at 13:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included COVID-19 infection, asthma since an unknown dates. The concomitant medications included duloxetine hydrochloride (CYMBALTA), allopurinol (ELAVIL), lurasidone hydrochloride (LATUDA), alprazolam (XANAX) and omeprazole (OMEPRAZOL) for an unknown indications, from an unknown dates and unknown if ongoing. The patient previously received levofloxacin (LEVAQUIN) and ciprofloxacin (CIPRO) and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021, at 13:30, the patient experienced severe headache, 101.8 far(Fahrenheit) fever, arm pain, myalgia, dizziness, difficulty walking, severe pressure in head, akathesia, agitation, eye pain, sensitivity to light, tinnitus, nausea, vomiting and sore throat. Therapeutic measure were taken as a result of adverse event which included treatment with non-steroidal anti-inflammatory drugs (NSAIDs). The clinical outcome of the events severe headache, 101.8 101.8 far(Fahrenheit) fever, arm pain, myalgia, dizziness, difficulty walking, severe pressure in head, akathesia, agitation, eye pain, sensitivity to light, tinnitus, nausea, vomiting and sore throat was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Fatigue
Clinical narrative: After taking the first dose of the vaccine with 19 hours felt very tired and felt too much heaviness on  chest and chest pain.; After taking the first dose of the vaccine with 19 hours felt very tired and felt too much heaviness on  chest and chest pain.; After taking the first dose of the vaccine with 19 hours felt very tired and felt too much heaviness on  chest and chest pain.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: er:8737) via an unspecified route of administration in the arm left on 05Apr2021 at 14:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included bronchial allergies, environmental allergy and allergy to chemicals products such as (paint, cleaning products). Concomitant medications included esomeprazole magnesium (NEXIUM) tablets on an unknown date and for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 12:00 within 19 hours of vaccination, the patient experienced very tired, felt too much heaviness on chest and chest pain. The patient reported that she had bronchial allergies and was very sensitive to even smell, any cleaning chemicals products or paint. They made her sick. Because of the events she called the center where she got the vaccine and informed them and they told her to go to the ER(emergency department). She went to the ER and after all the tests made in 8 hours the doctor informed her that the tests are fine but he said to contact Pfizer because she might not be able to get the second dose. Until 09Apr2021, she was feeling a bit better but was tired even though she was using the Ventolin inhaler as the doctor advised. The adverse event resulted in emergency room/department or urgent care. The patient received Ventolin inhaler as the treatment for the reported events. The clinical outcome of the event very tired, felt too much heaviness on chest and chest pain was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Body temperature, Diarrhoea, Illness, Lethargy
Clinical narrative: lethargic; extremely sick; Diarrhea; vomiting; fever; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 22Feb2021 at 12:30 (at the age of 68 year old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD) and coronary heart disease (CHD), latex allergy since an unknown date. The patient received prescribed medications/supplement within two weeks of vaccination. The patient previously took Hydrocodeine and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Feb2021, the patient underwent blood test and the result was negative. On 22Feb2021, the patient underwent covid-19 test and the result was negative. On 23Feb2021 at 10:30, the patient was extremely sick with diarrhea, vomiting and a fever of 99 degrees and was lethargic for 3 days following. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events as the physician tested the patient for COVID antibodies test and the result was none. The clinical outcome of the events sick, diarrhea, vomiting, fever and lethargic was recovered with sequelae at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-1 test, SARS-CoV-2 antibody test, Vomiting
Clinical narrative: lethargic; extremely sick; Diarrhea; vomiting; fever; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 22Feb2021 at 12:30 (at the age of 68 year old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD) and coronary heart disease (CHD), latex allergy since an unknown date. The patient received prescribed medications/supplement within two weeks of vaccination. The patient previously took Hydrocodeine and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Feb2021, the patient underwent blood test and the result was negative. On 22Feb2021, the patient underwent covid-19 test and the result was negative. On 23Feb2021 at 10:30, the patient was extremely sick with diarrhea, vomiting and a fever of 99 degrees and was lethargic for 3 days following. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events as the physician tested the patient for COVID antibodies test and the result was none. The clinical outcome of the events sick, diarrhea, vomiting, fever and lethargic was recovered with sequelae at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Pain, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: Severe achiness; vomiting; dizziness; fever; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old unknown gender patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 06Apr2021 at 17:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and heart condition. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient was allergic to sulfa medication. The patient did not receive any other medications within 2 weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced severe achiness, vomiting for 24 hours, dizziness, fever and sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event vomiting, dizziness, fever and sore arm were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: Irregular bleeding and mensuration cycle just after the vaccination.; Ongoing mensuration since 3 weeks; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Mar2021(at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis from 2014. Concomitant medications included methotrexate (MANUFACTURER UNKNOWN) and hydroxychloroquine (MANUFACTURER UNKNOWN) for unknown indication from an unspecified  date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 00:00, the patient experienced irregular bleeding and mensuration cycle just after the vaccination. Ongoing mensuration since 3 weeks since the vaccine was taken and could lead to need for doctors opinion. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events irregular bleeding and mensuration cycle and ongoing mensuration since 3 weeks was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Headache, Pain, Pain in extremity
Clinical narrative: An intense, sharp pain in variety of areas (at different times).; Would have a bruise; From 30 minutes to an hour late, would have a bruise. Worst one was in pinky, like a vein burst.; Would be sore in that spot for a day or so. Worst one was in pinky.; Would have a bruise, one in the back of my head.; Would be sore in that spot for a day or so, one in the back of my head.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0142) via an intramuscular route of administration in the right arm on 29Dec2020 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included HBP (high blood pressure), depression and hyperlipidemia. The patient had no known allergies to medications, food, or other products. The patient received unspecified medication within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Jan2021, the patient experienced an intense, sharp pain in variety of areas (at different times) and from 30 minutes to an hour late, she would have a bruise which would be sore in that spot for a day or so. The worst one was in the pinky, which felt like a vein burst and then one in the back of the head. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events an intense, sharp pain in variety of areas (at different times), bruise that would be sore in that spot for a day or so and worst one in pinky, and then one in the back of the head was resolved on an unknown date in 2021. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration in the right arm on 19Jan2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Vaccination site pain, Vaccination site rash
Clinical narrative: Rash at the injection site with a slight raised area at the center; Rash is red and slightly itchy; Soreness at injection site; This is a spontaneous report from a contactable consumer, the parent. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the right arm on 01Apr2021 at 13:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal hay fever, eczema and allergy to metals such as nickel. Concomitant medications included norethisterone acetate, ethinylestradiol (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) from an unknown date as birth control. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021, the patient experienced soreness at injection site the day of injection and the day after. The patient had no other side effects. On 09Apr2021 at 09:00, the patient experienced a rash at the injection site with a slight raised area at the center. The rash was red and slightly itchy. The rash was approximately 1.5 by 1.5 inches. The patient did not experience any other side effects (as reported). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event soreness at injection site, rash at the injection site with a slight raised area at the center which was red and slightly itchy were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: Headache; Chills; full body soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 31-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 10Mar2021 (at the age of 31-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 22:00, the patient experienced headache, chills and full body soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events  headache, chills and full body soreness was recovered on an unknown date of Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Headache
Clinical narrative: Chills; Headaches; Stomach issues; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Mar2021 at 09:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to food, medications, or other products. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021 at 17:00, the patient experienced chills, headaches, stomach issues. For 8 days, the patient had chills headaches stomach issues. The patient did not receive any treatment for events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care visit. The clinical outcome of the events chills, headaches, stomach issues were not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Pyrexia, Swelling face
Clinical narrative: Swelling in the right side of the face from the ear to the throat/ Then, swelling in the other side; Tiredness and general discomfort; Tiredness and general discomfort.; Light fever; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 07Apr2021 at 09:00(at the age of 48-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN) for unknown indications and from an unknown date. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 18March2021 at 15:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 07:00 the patient experienced swelling in the right side of the face from the ear to the throat, 12 hours after the shot. Then, experienced swelling in the other side, tiredness, general discomfort and light fever. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swelling in the right side of the face from the ear to the throat, swelling in the other side, tiredness, general discomfort and light fever were not recovered, at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Conjunctivitis, Eye pain, Eye swelling, Feeling abnormal, Irritability
Clinical narrative: Rash on right arm very itchy; Very itchy and irritating; Pain in left eye/eye ball pain; Feels like pink eye; Left eye more pain to touch than swelling.; weird sensation if drinking alcohol, felt really strange and can not drink; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 24Mar2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis. The patient did not have any allergies to food, medicine and other product. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the right arm on 03Mar2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, two weeks after the vaccination, the patient experienced rash on right arm, very itchy and irritating and on the third day it was getting worse. The patient also experienced pain in left eye which felt like pink eye, but more pain to touch than swelling, the pain moved up into the eye ball. The patient also had a very weird sensation when drinking alcohol, he had one sip and felt really strange and could not drink. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events rash on right arm which was very itchy and irritating, pain in left eye which felt like pink eye with more pain to touch than swelling, weird sensation when drinking alcohol which felt really strange and can not drink was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Rash on right arm very itchy; Very itchy and irritating; Pain in left eye/eye ball pain; Feels like pink eye; Left eye more pain to touch than swelling.; weird sensation if drinking alcohol, felt really strange and can not drink; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 24Mar2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis. The patient did not have any allergies to food, medicine and other product. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the right arm on 03Mar2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, two weeks after the vaccination, the patient experienced rash on right arm, very itchy and irritating and on the third day it was getting worse. The patient also experienced pain in left eye which felt like pink eye, but more pain to touch than swelling, the pain moved up into the eye ball. The patient also had a very weird sensation when drinking alcohol, he had one sip and felt really strange and could not drink. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events rash on right arm which was very itchy and irritating, pain in left eye which felt like pink eye with more pain to touch than swelling, weird sensation when drinking alcohol which felt really strange and can not drink was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Epistaxis, Joint stiffness, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: arm and joints feel stiff; arm and joints feel stiff; felt dizzy; sharp shooting pain down my right arm.; My nose suddenly started to bleed (stopped after ~2 mins); This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 09Apr2021 at 17:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to tree Nuts and eggs.  Concomitant medications included Birth Control, Collagen supplements, Multi-vitamin; all from unknown date for unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 19Mar2021 at 16:45 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was  not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 17:45 about 30 minutes after the dose, the patient felt a little dizzy, then had a sharp shooting pain down right arm. Her nose suddenly started to bleed(stopped after ~2 mins). On 09Apr2021 at 18:15 after an hour had passed, patient experienced arm and joints feel stiff. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events dizzy,  sharp shooting pain down right arm and arm and joints stiff were unknown and of the nose bleeding was recovered on 09Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Lethargy, Pain, Pyrexia
Clinical narrative: Fever; Chills; Body ache; Lethargy; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El9263) via an unspecified route of administration in the right arm on 19Feb2021 at 12:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included unspecified condition. The patient was not allergic to medications, food, or other products. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El1283) via an unspecified route of administration in the right arm on 29Jan2021 at 12:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Feb2021 at 16:00, the patient experienced fever, chills, body ache and lethargy. The patient had events of fever and chills for 24 hours, and body ache and lethargy for 3 days. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fever and chills resolved on 20Feb2021 at 16:00, and body ache and lethargy resolved on 22Feb2021.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Erythema, Pruritus, Skin warm, Swelling
Clinical narrative: Next day Saturday, blisters started to form on top of the toes; Evening of second shot foot started to itch, itching increase over the week and by the following Friday two toes are unbearable itching; Friday two toes were red; Friday two toes were hot; Friday two toes were swollen; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 26Mar2021 at 08:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and kidney donor (donated a kidney). Concomitant medications included norethisterone (NORETHINDRONE), vitamin d (vit d) (MANUFACTURER UNKNOWN), levothyroxine (l-thyroxine) (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN) for unknown indication, from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 05Mar2021 at 08:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient received penicillin (MANUFACTURER UNKNOWN) and amoxicillin (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 26Mar2021 at 22:00, in the evening of second shot, the patient foot started to itch, itching increase over the week and by the following Friday two toes were swollen, red, hot and unbearable itching. On 27Mar2021, next day, Saturday, blisters started to form on top of the toes. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events and included treatment with methylprednisolone tablets (MANUFACTURER UNKNOWN) and mupirocin ointment (MANUFACTURER UNKNOWN). The clinical outcome of the events itching, two toes were swollen, red, hot and blisters started to form on top of the toes was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Myalgia
Clinical narrative: Extreme joint and muscle pain; Extreme joint and muscle pain; chills; exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8627) via an unspecified route of administration in the arm left on 07Apr2021 at 09:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included arthritis. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN), cannabidiol (MANUFACTURER UNKNOWN), biotin (MANUFACTURER UNKNOWN), cod-liver oil (FISH OIL) and cyanocobalamin-tannin complex (B12); all from an unknown date for an unknown indication. The patient had no known allergies to medications, food or other products. The patient previously took first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 17Mar2021 at 09:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 16:00 the patient experienced Extreme joint and muscle pain, chills and exhaustion. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event.  The clinical outcome of the events muscle pain, joint pain, chills and exhaustion was recovered on unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pustule, Rash pruritic
Clinical narrative: Rash all over my extremities, started on lower legs and moved up and was very itchy; Rash with some pus; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient was not allergic to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 24Feb2021 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, two and a half weeks following the second shot, the patient experienced rash all over his extremities. It started on his lower legs and moved up. The event rash was very itchy with some pus. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events rash all over extremities started on lower legs and moved up, very itchy with some pus were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Epistaxis, Headache, Heart rate increased, Hypertension
Clinical narrative: Bloody nose; Rapid heart rate; High blood pressure; Nausea; Vomiting; Severe chills; Body aches; Blinding headache; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er2613) via an unspecified route of administration in the right arm on 26Mar2021 at 13:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis. The patient was allergic to unspecified medications, food, or other product. The patient received unspecified concomitant medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 14:00, the patient experienced bloody nose, rapid heart rate, high blood pressure, nausea, vomiting, severe chills, body aches and blinding headache. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the events which included treatment with TOURADOL, BENADRYL, ZOFRAN, ATIVAN and unspecified pain medications. The clinical outcome of the events bloody nose, rapid heart rate, high blood pressure, nausea, vomiting, severe chills, body aches and blinding headache was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Vomiting
Clinical narrative: Bloody nose; Rapid heart rate; High blood pressure; Nausea; Vomiting; Severe chills; Body aches; Blinding headache; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er2613) via an unspecified route of administration in the right arm on 26Mar2021 at 13:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis. The patient was allergic to unspecified medications, food, or other product. The patient received unspecified concomitant medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 14:00, the patient experienced bloody nose, rapid heart rate, high blood pressure, nausea, vomiting, severe chills, body aches and blinding headache. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the events which included treatment with TOURADOL, BENADRYL, ZOFRAN, ATIVAN and unspecified pain medications. The clinical outcome of the events bloody nose, rapid heart rate, high blood pressure, nausea, vomiting, severe chills, body aches and blinding headache was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Paraesthesia
Clinical narrative: Headache; Gradual tingling down the arm to fingers; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included smoker and penicillin allergy. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Apr2021 at 10:15, fifteen minutes after injection, the patient experienced gradual tingling down the arm to fingers which lasted half hour and then went away (at 10:45). The patient experienced sore arm on first (06Apr2021) and second (07Apr2021) day. The patient experienced headache on second day (07Apr2021). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event tingling was resolved on 06Apr2021 after half hour while sore arm and headache were resolved on 07Apr2021.   No follow-up attempts are needed. No further information is expected.